Further in vitro studies indicate that silencing of Rab31 in HCC cells reduces PI3K activation, P101 expression, phosphorylation of AKT and also decreases the BCL-2/BAX expression ratios favoring activation over inhibition of apoptosis [57]. This evidence concerns the gene AKT1 and hepatocellular carcinoma.